Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. Its products include Immune Medicine Platform, a software that uses proprietary chemistry, computational biology, and machine learning to read the genetic code of a patient’s immune system; Immunosequencing, a system that delivers fundamental insights into the body’s response to disease and therapy at the cellular level; clonoSEQ, a platform for detecting and monitoring minimal residual disease (MRD) in lymphoid cancers, etc. The company serves life sciences research, clinical diagnostics, and drug discovery applications.